Bezafibrate-impurities | Pharmaffiliates

bezafibrate

Bezafibrate improves markers of combined hyperlipidemia, effectively reducing LDL and triglycerides and improving HDL levels. Reference standards of Bezafibrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Bezafibrate (B1115000)
    [catalogue_number] => PA EPB1115000
    [category_ids] => ,150,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => bezafibrate-b1115000-paepb1115000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Bezafibrate (B1115000)


  • Catalogue No.:PA EPB1115000

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA